Sisunatovir

RV521 is a potent small molecule fusion inhibitor designed to combat Respiratory Syncytial Virus (RSV) by targeting the viral surface protein essential for host cell entry. It is widely used in virology and antiviral research for both in vitro mechanistic studies and in vivo efficacy evaluations in animal models of RSV infection.